German Drugmaker Evertz Pharma Adds 100 BTC to Corporate Treasury

German pharmaceutical company Evertz Pharma has increased its cryptocurrency holdings by acquiring 100 Bitcoin, worth around €10 million. This addition reflects the company’s long-term financial strategy and a commitment to integrating Bitcoin into their treasury reserve. The news comes as part of Evertz Pharma’s plan to diversify their investment portfolio and adapt to changing financial landscape. Established in 2020, the company has been steadily increasing its Bitcoin holdings through regular reinvestment of profits, demonstrating a proactive approach towards cryptocurrency adoption.